Needham analyst Alex Henderson reiterates Zscaler (NASDAQ:ZS) with a Strong Buy and maintains $210 price target.
TG Therapeutics Highlights Publication Of Results From Integrated Safety Analysis Of UKONIQ In Blood Advances
TG Therapeutics, Inc. (NASDAQ:TGTX) today announced the publication of results from an integrated safety analysis of UKONIQ® (umbralisib), the Company’s inhibitor of PI3k-delta and CK1-epsilon, in patients